Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Actu-Real Inc. and Jehangir Clinical Dev Centre Announce Strategic Collaboration to Further Real-world Research

Actu-Real Inc., a US-based specialized Contract Research Organization (CRO) focused on data analytics and Real-World Evidence (RWE) and Jehangir Clinical Development Centre (JCDC), a pioneering CRO conducting world-class clinical and medical research in India, announced the signing of a strategic collaboration agreement to further research based on RWE.

Through this collaboration, Actu-Real and JCDC will focus on collecting and analyzing real world data (RWD) generated from clinical practice to support evidence-based clinical, economic and regulatory decisions. J-ARC’s experience across the continuum of clinical development and post-approval research, global delivery model and expertise in design, conduct and analysis places it in a unique position to support such studies. The scientific and research community including pharma, biotech, research institutes, hospitals and healthcare companies will greatly benefit from this collaboration.

Recommended AI News: Flytxt to deploy its Customer Lifetime Value Management solution across all Orange OpCos

Related Posts
1 of 33,644

“This joint initiative aligns with Actu-Real’s mission to enable better results through evidence-based decisions in healthcare and our vision to implement an outcomes-based approach to healthcare access,” said Dr. Chitra Lele, President and founder of Actu-Real, Inc. Prior to founding Actu-Real, Dr. Chitra was a founding member of Sciformix which was acquired by Covance (Lab Corp), in 2018. Dr. Pierre Etienne, CMO and Co-founder of Actu-Real added that, “This collaboration will offer well-crafted solutions to all stakeholders of real-world research.”

“JCDC is a world class research center which is nationally and internationally recognized,” said Mr. Jehangir H.C. Jehangir, Chairman of JCDC. “We are excited about our collaboration with Actu-Real, which will facilitate meaningful research and strengthen our abilities to improve health,” Mr. Pathik Divate, CEO of JCDC further added.

Recommended AI News: Evolve IP and Cisco Deepen Partnership to Deliver Evolve Anywhere with Webex

[To share your insights with us, please write to]

Comments are closed.